The FDA's eMDR program supports the electronic submission of Medical Device Reports (MDRs) required under applicable post-market reporting regulations. Electronic reporting enables the FDA to receive, review, and archive adverse event information more efficiently while helping manufacturers and importers meet regulatory reporting obligations. Manufacturers and importers are generally required to submit MDRs electronically unless an exemption has been granted by the FDA.
The eMDR system utilizes standardized electronic reporting formats and the FDA's Electronic Submissions Gateway (ESG NextGen) to facilitate secure transmission and processing of reports. Both low-volume and high-volume reporting options are available, allowing organizations to select a submission method appropriate to their reporting needs.
Key Elements of an Effective eMDR Compliance Program
- Adverse Event Identification and Assessment: Procedures for detecting, evaluating, and determining whether device-related incidents meet MDR reporting requirements.
- Electronic Submission Process: Preparation and submission of MDRs through FDA-approved electronic systems using the required reporting format.
- Data Accuracy and Completeness: Collection and verification of all required information, including device details, event descriptions, and patient outcomes.
- Follow-up and Supplemental Reporting: Processes for updating previously submitted reports when new or corrected information becomes available.
- Acknowledgment and Tracking Management: Review of FDA acknowledgment files to confirm successful receipt and acceptance of submitted reports.
- Recordkeeping and Documentation: Maintenance of complaint files, investigation records, submitted reports, and supporting documentation to demonstrate compliance.
- System Validation and Training: Ensuring reporting systems function properly and personnel are trained on MDR regulations and electronic submission requirements.
- Post-Market Surveillance Integration: Alignment of eMDR activities with complaint handling, vigilance, risk management, and corrective and preventive action (CAPA) processes.
Following these recommendations helps manufacturers maintain compliance with FDA post-market reporting requirements while supporting timely identification and communication of device-related safety issues. The eMDR framework enhances regulatory oversight, facilitates efficient adverse event reporting, and contributes to the continued safety and effectiveness of medical devices throughout their lifecycle.
Contact Qualtech for supporting your conformity assessment strategy and regulatory compliance journey across Europe.